Market revenue in 2023 | USD 34.3 million |
Market revenue in 2030 | USD 52.9 million |
Growth rate | 6.4% (CAGR from 2023 to 2030) |
Largest segment | Anti-bacterial |
Fastest growing segment | Anti-fungal |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Anti-bacterial, Anti-fungal, Corticosteroids, Others (Acaricidals, Cyclosporins) |
Key market players worldwide | Zoetis, Elanco Animal Health Inc, Dechra Pharmaceuticals, Merck & Co Inc, Vetoquinol SA, Virbac SA, CEVA Inc, Penn Veterinary Supply Inc, Vedco |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to companion animal ear infection treatment market will help companies and investors design strategic landscapes.
Anti-bacterial was the largest segment with a revenue share of 44.02% in 2023. Horizon Databook has segmented the Germany companion animal ear infection treatment market based on anti-bacterial, anti-fungal, corticosteroids, others (acaricidals, cyclosporins) covering the revenue growth of each sub-segment from 2018 to 2030.
Germany companion animal ear infection treatment market is expected to grow due to rising disposable income and a proportionate increase in interest in farm & companion animals. According to Industry Association of Pet Care Producers and the German Pet Trade & Industry Association (ZZF), the number of pets in Germany increased by 5% in 2020 over the previous year.
According to an article published in Pet food industry, in 2019, the country’s canine population increased by 700,000 in 2018. The population of small animals was estimated at around 5.2 million and that of pet birds was at 4 million in 2019.
Increase in government initiatives, growing risk of emerging zoonotic diseases, and leading innovations in veterinary healthcare are major factors likely to drive the market over the forecast period. In February 2020, German company Verovaccines GmbH signed a cooperation agreement with an international veterinary pharmaceutical company, supporting the country’s market.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany companion animal ear infection treatment market , including forecasts for subscribers. This country databook contains high-level insights into Germany companion animal ear infection treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account